Skip to main content

Hemoglobinopathy clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

    Sorry, in progress, not accepting new patients

    This clinical trial is a Phase 2/3 study that will evaluate the efficacy and safety of etavopivat and test how well etavopivat works compared to placebo to improve the amount of hemoglobin in the blood and to reduce the number of vaso-occlusive crises (times when the blood vessels become blocked and cause pain).

    Irvine 5359777, California 5332921 and other locations

Last updated: